Home
OvaScience

OvaScience Market Share Analysis for May 2026

KASPOKER adalah situs judi idn slot gacor hari ini terpercaya dan game judi idn poker online membuka portal daftar akun poker dan slot gacor maxwin link alternatif tanpa vpn.

Health > Biotechnology and Pharmaceuticals

Domainovascience.com

Year Founded2011

Employees51 - 200

Annual Revenue< $1M

OvaScience

OvaScience (including company regionals)

ovascience.com

See more website traffic and engagement information

Total visits to OvaScience's top domains

Understand OvaScience market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in OvaScience's top domains

Analyze OvaScience engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on OvaScience's top domains

See how OvaScience keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

OvaScience top competitors by domain

Top similar sites in May 2026, ranked by their affinity

fiercebiotech.comCompany NameFierceBiotechEmployees51 - 200HQUnited States, Missouri, Lees SummitAnnual revenue$1M - $2MTotal visits679.2KHealth > Biotechnology and Pharmaceuticals

Top technologies used by OvaScience

These are the website technologies, by industry, used by OvaScience top domains

Advertising (3)

Google Adsense

Email Services (2)

GoDaddy Email

Marketing (2)

HubSpot

Mobile (2)

Meta Viewport

More Technologies

3

See all

News & Signals from OvaScience

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsOvaScience, Inc has issues with alleged violations of the federal securities laws.The litigation asserts claims for alleged violations of the federal securities laws against OvaScience, Inc. ("OvaScience" or the "Company"), Michelle Dipp, M.D., Ph.D., and Jeffrey E. Young.

NewsOvaScience, Inc is developing OvaPrimeSM treatment.OvaScience is developing the OvaPrime℠ treatment, which could increase a woman’s egg reserve and the OvaTure℠ treatment, a potential in vitro fertilization (IVF) treatment that could help a woman produce new fertilizable eggs without hormone injections.

NewsOvaScience, Inc hired James Lillie as Chief Scientific Officer on Jan 1st '18.In January 2018, OvaScience announced the appointment of James Lillie, Ph.D., as Chief Scientific Officer.